J B Chemicals and Pharmaceuticals : EU approval for manufacturing facility at Panoli, Gujarat

Press Release_______________________________________________________________________________

BSE Scrip Code: 506943

NSE Symbol: JBCHEPHARM

Mumbai, January 17, 2018

J.B. Chemicals receives EU approval

J.B. Chemicals & Pharmaceuticals Limited (JBCPL) is pleased to announce receipt of European GMP Approval for its formulation facilities in Panoli, Gujarat, India from Medicines Authority of Malta.

The inspection is outcome of a successful cGMP inspection carried out in September/October 2017. According to the certificate received, the following dosage formulations are found to be GMP compliant for manufacturing and testing.

• 1) Capsules

• 2) Liquids (for internal use)

• 3) Semi Solids (topical preparations like Ointments, Creams and Gels).

• 4) Tablets

JBCPL's tablet facility already enjoys recurrent USFDA as well as EU cGMP compliance.

Addition of other dosage form like Capsules, Liquids and Semi Solids will open the door of EU as well as PIC/S market for these formulations manufactured at Company's State-of-the-Art manufacturing facilities situated at Panoli.

The Company also intends to explore possibility of contract manufacture these formulations for EU market to leverage the approval.

JBCPL has world class Lozenges manufacturing facility in Daman, India, which also has cGMP accredited by EU Authorities in the year 2017. Thus, Company's all formulations manufacturing facilities (non-sterile) enjoy EU approval.

********

About JBCPL:

JBCPL, one of India's leading pharmaceutical companies, manufactures & markets a diverse range of pharmaceutical formulations, herbal remedies and APIs. JBCPL exportsto many countries worldwide with presence in US, Europe, Australia, South Africa, other developing countries, Russia and CIS. The Company continues to invest in growing its share in the regulated markets in USA, Europe and Australia. JBCPL has a strong R & D and regulatory set-up for development of new drug delivery system and formulations, filing of ANDAs and DMFs. Its State-of-the-Art manufacturing facilities are approved by health authorities of important regulated markets.

For more information on JBCPL visit our website atwww.jbcpl.com.For more details, you may contact:

M.C. Mehta

Company Secretary and Vice President- Compliance J. B. Chemicals & Pharmaceuticals Ltd.

91 22 2439 5311

-- x --

Forward Looking Statements:

This Press Release may contain Forward Looking Statements regarding future events and future performance of J.B. Chemicals & Pharmaceuticals Ltd. that involve risks and uncertainties that could cause actual results to differ materially from those that may be indicated by such statements.